B. Riley Securities initiated coverage on Abacus Life with a new price target
$ABL
Investment Managers
Finance
B. Riley Securities initiated coverage of Abacus Life with a rating of Buy and set a new price target of $16.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/29/2025 | $14.00 | Buy | Maxim Group |
| 10/24/2024 | $13.50 | Outperform | Northland Capital |
| 8/7/2024 | $14.00 | Buy | TD Cowen |
| 6/26/2024 | $12.00 | Overweight | Piper Sandler |
| 5/31/2024 | $16.00 | Buy | B. Riley Securities |
ORLANDO, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leader in the alternative asset management space, announced the public launch of their new corporate-focused commercial campaign on June 12th, 2025, at their Investor Day and Longevity Summit held at Nasdaq in New York City. The campaign is centered around Abacus' positioning as a visionary leader in longevity-based asset management. In the commercial, Abacus CEO Jay Jackson depicts the Company's mission to "reframe the very nature of financial planning around the most personal data point possible: your lifespan." Jackson said, "This launch represents our commitment
ORLANDO, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leader in the alternative asset management space, today provided the following response to last week's false and misleading short attack. Our shareholders have been subjected to a false and uninformed short attack. The short seller's report published on June 4, 2025 makes two key allegations: first, that Abacus relies too heavily on a single life expectancy provider (Lapetus Solutions), and second, that this reliance has significantly inflated our balance sheet valuation. Both are incorrect. Abacus remains resolute in our process, valuation methodology, and the bene
ORLANDO, Fla., June 06, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a leader in the alternative asset management space, today announced that its Board of Directors has authorized a new $20 million share repurchase program, effective June 5, 2025 for over a period of up to 18 months, as well as recent Form 4 and other employee share purchases totaling over $2 million. "While it is unfortunate that Abacus Global Management has been subject to a short attack, we believe our artificially depressed share price represents an excellent buying opportunity for the Company," said Jay Jackson, Chief Executive Officer of Abacus Global Management.
Maxim Group initiated coverage of Abacus Global Management with a rating of Buy and set a new price target of $14.00
Northland Capital initiated coverage of Abacus Life with a rating of Outperform and set a new price target of $13.50
TD Cowen initiated coverage of Abacus Life with a rating of Buy and set a new price target of $14.00